AlphaFold predicted structure
ADNP · Q9H2P0

Mean pLDDT
56.2/ 100
Low
1,102 residues
Confidence breakdown
- Very high(≥ 90)5%
- Confident(70–90)31%
- Low(50–70)10%
- Very low(< 50)54%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
activity dependent neuroprotector homeobox
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedClefting
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder
ADNP-related multiple congenital anomalies-intellectual disability-autism spectrum disorder
hereditary disease
Intellectual disability
neurodegenerative disease
prostate carcinoma
Global developmental delay
neurodevelopmental disorder
Seizure
autism spectrum disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Activity-dependent neuroprotector homeobox protein
May be involved in transcriptional regulation. May mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation. Positively modulates WNT-beta-catenin/CTNN1B signaling, acting by regulating phosphorylation of, and thereby stabilizing, CTNNB1. May be required for neural induction and neuronal differentiation. May be involved in erythroid differentiation (By similarity)
ADNP · Q9H2P0

Mean pLDDT
56.2/ 100
Low
1,102 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0